Cabinet reaffirms Saudi position of resolving conflicts through diplomatic means    Saudi FM receives message from Iranian counterpart    AlUla becomes favorite global summer destination for photography enthusiasts    Foreign Trade Authority leads Saudi negotiating team in second round of GCC-Japan FTA Talks    Crown Prince extends period of study to regulate landlord-tenant relationship to 90 days    130 charities say controversial Gaza aid group must be shut down    Inzaghi hails 'historic' Al Hilal win over Man City: We climbed a mountain with no oxygen    Milinković-Savić says Al Hilal proved critics wrong after historic win over Man City    Al Hilal stuns Man City and stirs the world: 'One of the greatest nights in Saudi club football'    Michelin Guide launches in Saudi Arabia with phased rollout in 2025    Spanish PM's former aide detained without bail in corruption probe    US skips global UN meeting in Spain aimed at raising trillions to combat poverty    Al Hilal stun Manchester City in seven-goal thriller to reach Club World Cup quarterfinals    EU and Ukraine strike less ambitious but 'realistic' trade deal    'How fragile we are': Roskilde Festival tragedy remembered 25 years on    New Social Insurance Law comes into force on Tuesday    Over 190,000 Umrah visas issued since start of the season    PIF assets soar to $1.15 trillion in 2024    Historic Jeddah's visual identity re-imagined through global art installations at Al-Arbaeen Lagoon    Brad Pitt's Los Angeles home 'ransacked', police say    Sholay: Bollywood epic roars back to big screen after 50 years with new ending    Ministry launches online booking for slaughterhouses on eve of Eid Al-Adha    Shah Rukh Khan makes Met Gala debut in Sabyasachi    Pakistani star's Bollywood return excites fans and riles far right    Exotic Taif Roses Simulation Performed at Taif Rose Festival    Asian shares mixed Tuesday    Weather Forecast for Tuesday    Saudi Tourism Authority Participates in Arabian Travel Market Exhibition in Dubai    Minister of Industry Announces 50 Investment Opportunities Worth over SAR 96 Billion in Machinery, Equipment Sector    HRH Crown Prince Offers Condolences to Crown Prince of Kuwait on Death of Sheikh Fawaz Salman Abdullah Al-Ali Al-Malek Al-Sabah    HRH Crown Prince Congratulates Santiago Peña on Winning Presidential Election in Paraguay    SDAIA Launches 1st Phase of 'Elevate Program' to Train 1,000 Women on Data, AI    41 Saudi Citizens and 171 Others from Brotherly and Friendly Countries Arrive in Saudi Arabia from Sudan    Saudi Arabia Hosts 1st Meeting of Arab Authorities Controlling Medicines    General Directorate of Narcotics Control Foils Attempt to Smuggle over 5 Million Amphetamine Pills    NAVI Javelins Crowned as Champions of Women's Counter-Strike: Global Offensive (CS:GO) Competitions    Saudi Karate Team Wins Four Medals in World Youth League Championship    Third Edition of FIFA Forward Program Kicks off in Riyadh    Evacuated from Sudan, 187 Nationals from Several Countries Arrive in Jeddah    SPA Documents Thajjud Prayer at Prophet's Mosque in Madinah    SFDA Recommends to Test Blood Sugar at Home Two or Three Hours after Meals    SFDA Offers Various Recommendations for Safe Food Frying    SFDA Provides Five Tips for Using Home Blood Pressure Monitor    SFDA: Instant Soup Contains Large Amounts of Salt    Mawani: New shipping service to connect Jubail Commercial Port to 11 global ports    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Janssen partners with National Guard Hospital to offer breakthrough genetic testing to leukemia patients
Published in The Saudi Gazette on 27 - 10 - 2021

Janssen, the pharmaceutical companies of Johnson and Johnson, one of the world's leading healthcare companies, Wednesday announced the successful completion of a knowledge transfer program which is improving outcomes for leukemia patients in Saudi Arabia.
In cooperation with the Ministry of National Guard Health Affairs, the initiative offers vital genetic testing to patients with chronic lymphocytic leukemia (CLL), to ensure the most appropriate treatment is given, and prognosis and outcomes are improved. Supported by the Saudi Society of Blood and Marrow Transplantation, (SSBMT) this is the first time this vital test has been offered in the region.
Identifying the presence of a mutation within the immunoglobulin heavy-chain variable region gene (IGHV) is a vital tool in treating CLL. It is recognized as a marker of overall survival rate, and an acknowledged prognostic factor in the disease. Identification of the mutation ensures the most appropriate treatment is given to improve patient outcomes. IGHV testing is mandatory under international clinical guidelines for CLL, however identifying this biomarker has not previously been possible in the region.
Under the knowledge transfer project which sought to address this challenge, two pathologists were selected by the SSBMT receive training on the sophisticated Next Generation Sequencing technique in Switzerland. They then returned to Saudi with the knowledge and skills to train colleagues and establish testing capabilities in the Kingdom. The program, sponsored by Janssen, is in line with Saudi Vision 2030 of developing the Kingdom's healthcare capabilities and supporting localization within the healthcare sector.
CLL is the most common leukemia diagnosed in adults. The Saudi Cancer Registry report that leukemia is the fifth most common cancer in Saudi adults1, and the incidence of the disease is on the rise, due in part to an aging population. But while the average age of diagnosis is 70, increasing numbers are being diagnosed at a younger age within the Kingdom. Identifying those who are more likely to develop an aggressive form of the disease is vital to offer these patients the most appropriate, effective treatment, and increase survival rates.
Dr. Ahmed Alaskar, president of the Saudi Society of Blood and Marrow Transplantation (SSBMT) and executive director of King Abdullah International Medical Research Center, said, "Identifying a mutation in the IGHV gene is at the heart of guided CLL treatment. Without this type of information, doctors are often forced to treat CLL blindly, and there is a risk of treatment failure. CLL patients without the IGHV mutation are at a higher risk of receiving a poor prognosis.
"Identifying these patients helps the treating physician to offer personalized targeted therapy with higher success rates. When we understand the molecular basis of the disease, and ensure an individualized approach to treatment, we really can improve survival rates. Being able to offer CLL patients in the Kingdom this type of molecular testing is a real breakthrough."
SSBMT selected King Abdulaziz Medical City, Riyadh, part of Ministry of National Guard Health Affairs and King Fahad Specialist Hospital — Dammam, as partners for this project following a competitive selection process. The hospital was selected based on its stringent accreditations, an established team of molecular scientists, and a clear commitment to knowledge sharing with other facilities within their network with the aim of providing access for across the Kingdom. A representative from each institutions were sent to travel to Switzerland and receive training in the Next Generation Sequencing molecular testing for IGHV mutation.
Dr. Saeed Alturki, head of translational pathology lab, said, "I am pleased to be involved in a program that provides CLL patients, at a national level, access to precision oncology healthcare services. Collaborations such as this, between the private sector and our government, provide the opportunity to implement cutting-edge technologies within the genomics field, and crucially, extend this support to our colleagues in all hospitals. Together, we are benefitting the well-being of Saudi citizens and supporting the Saudi Vision 2030 of expanding the Kingdom's healthcare capabilities."
Mohammed Alquwaizani, general manager at Janssen Pharmaceutical Companies of Johnson & Johnson, Saudi Arabia, said, "For several decades, Janssen has been establishing public-private partnerships within the Kingdom to deliver groundbreaking solutions for patients with added value to the healthcare system. We are committed to — and invested in — supporting Saudi Arabia's position as a pioneer in healthcare capabilities.
"Collaborating with the Ministry National Guard Health Affairs and SSBMT to build local capabilities in the most sophisticated molecular screening techniques demonstrates that together, we can pioneer real progress and ensure that we offer the right treatments at the right time, for the right patient as we work towards making cancer a manageable, even curable, condition." — SG


Clic here to read the story from its source.